Lyphe Group
About Lyphe Group
Lyphe Group is Europe's largest medical cannabis platform, operating clinics, pharmacies, and technology infrastructure across the UK and Germany. The group's portfolio includes Mamedica clinics, LYPHE Dispensary pharmacy, and digital health tools for patient management. Lyphe Group has built an integrated ecosystem connecting patients, physicians, and cannabis product suppliers.
Key Facts
- 1Europe's largest integrated medical cannabis platform
- 2Operates Mamedica clinics in the UK and Germany
- 3Runs LYPHE Dispensary, a specialist cannabis pharmacy
- 4Has treated over 50,000 patients across its network
Frequently Asked Questions
What is Mamedica?
Mamedica is Lyphe Group's medical cannabis clinic brand, operating in the UK and Germany. The clinics provide specialist consultations and prescriptions for medical cannabis to patients with qualifying conditions.
Does Lyphe Group operate outside the UK?
Yes, Lyphe Group has expanded into Germany through its Mamedica clinics and pharmacy operations, making it one of the few cannabis healthcare companies operating across multiple European markets.
More Cannabis Companies in London
Cannabis Laws
Products
- Mamedica clinic consultations
- LYPHE Dispensary pharmacy services
- Digital patient management platform
Specialties
Company Details
- Type
- Medical & Pharma
- Location
- London, United Kingdom
- Founded
- 2019
- Publicly Traded
- No